{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:12:03Z","timestamp":1768443123878,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":3546,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1080\/13651820701216216","type":"journal-article","created":{"date-parts":[[2007,7,27]],"date-time":"2007-07-27T09:03:33Z","timestamp":1185527013000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["New advances in the management of biliary tract cancer"],"prefix":"10.1016","volume":"9","author":[{"given":"John","family":"Bridgewater","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Imber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/13651820701216216_bb0010","unstructured":"http:\/\/www.statistics.gov.uk."},{"key":"10.1080\/13651820701216216_bb0015","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"Patel","year":"2001","journal-title":"Hepatology"},{"key":"10.1080\/13651820701216216_bb0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1080\/13651820701216216_bb0025","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0046-8177(03)00337-X","article-title":"Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract","volume":"34","author":"Abraham","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1080\/13651820701216216_bb0030","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/hupa.2002.127444","article-title":"Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4\/Dpc4 in intrahepatic cholangiocarcinoma","volume":"33","author":"Kang","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1080\/13651820701216216_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000012139","article-title":"Bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phenotypes","volume":"59","author":"Ito","year":"2000","journal-title":"Oncology"},{"key":"10.1080\/13651820701216216_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1148\/radiol.2342040278","article-title":"Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT \u2013 initial observations","volume":"234","author":"Huppertz","year":"2005","journal-title":"Radiology"},{"key":"10.1080\/13651820701216216_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1572-0241.2003.04006.x","article-title":"EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology","volume":"99","author":"Fritscher-Ravens","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1080\/13651820701216216_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gassur.2003.10.003","article-title":"Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma","volume":"8","author":"Anderson","year":"2004","journal-title":"J Gastrointest Surg"},{"key":"10.1080\/13651820701216216_bb0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s005340050170","article-title":"Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience","volume":"7","author":"Nimura","year":"2000","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1080\/13651820701216216_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/PL00009951","article-title":"Aggressive surgical treatment of hilar cholangiocarcinoma","volume":"5","author":"Nimura","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1080\/13651820701216216_bb0065","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/bjs.5482","article-title":"Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma","volume":"93","author":"Liu","year":"2006","journal-title":"Br J Surg"},{"key":"10.1080\/13651820701216216_bb0070","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00000658-199912000-00010","article-title":"Extended resections for hilar cholangiocarcinoma","volume":"230","author":"Neuhaus","year":"1999","journal-title":"Ann Surg"},{"key":"10.1080\/13651820701216216_bb0075","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","article-title":"Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature","volume":"7","author":"Shimoda","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1080\/13651820701216216_bb0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1080\/13651820701216216_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00000658-200103000-00013","article-title":"Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection","volume":"233","author":"Kitagawa","year":"2001","journal-title":"Ann Surg"},{"key":"10.1080\/13651820701216216_bb0090","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00000658-199911000-00008","article-title":"Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection","volume":"230","author":"Kosuge","year":"1999","journal-title":"Ann Surg"},{"key":"10.1080\/13651820701216216_bb0095","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/lt.20266","article-title":"Transplantation for hilar cholangiocarcinoma","volume":"2","author":"Heimbach","year":"2004","journal-title":"Liver Transpl;10(10 Suppl"},{"key":"10.1080\/13651820701216216_bb0100","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00000658-199611000-00008","article-title":"Long-term results after resection for gallbladder cancer. Implications for staging and management","volume":"224","author":"Bartlett","year":"1996","journal-title":"Ann Surg"},{"key":"10.1080\/13651820701216216_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00000658-199801000-00011","article-title":"Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases","volume":"227","author":"Madariaga","year":"1998","journal-title":"Ann Surg"},{"key":"10.1080\/13651820701216216_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"key":"10.1080\/13651820701216216_bb0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjsurg.2004.01.007","article-title":"Outcomes after resection of cholangiocellular carcinoma","volume":"187","author":"Huang","year":"2004","journal-title":"Am J Surg"},{"key":"10.1080\/13651820701216216_bb0120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archsurg.139.5.514","article-title":"Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients","volume":"139","author":"Rea","year":"2004","journal-title":"Arch Surg"},{"key":"10.1080\/13651820701216216_bb0125","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0039-6060(96)80089-4","article-title":"Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage","volume":"120","author":"Tsukada","year":"1996","journal-title":"Surgery"},{"key":"10.1080\/13651820701216216_bb0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/ejso.2002.1301","article-title":"Long-term follow-up of surgically treated gallbladder cancer patients","volume":"28","author":"Puhalla","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"10.1080\/13651820701216216_bb0135","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1080\/13651820701216216_bb0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(98)00509-4","article-title":"Radiotherapy and multimodality management of cholangiocarcinoma","volume":"44","author":"Urego","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl","key":"10.1080\/13651820701216216_bb0145","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/BF00687120","article-title":"Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies","volume":"31","author":"Shiina","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1080\/13651820701216216_bb0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1097-0142(19910715)68:2<289::AID-CNCR2820680213>3.0.CO;2-2","article-title":"Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases","volume":"68","author":"Flickinger","year":"1991","journal-title":"Cancer"},{"key":"10.1080\/13651820701216216_bb0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00130404-200201000-00013","article-title":"High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma","volume":"8","author":"Lu","year":"2002","journal-title":"Cancer J"},{"key":"10.1080\/13651820701216216_bb0160","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/1097-0142(19801115)46:10<2179::AID-CNCR2820461014>3.0.CO;2-Y","article-title":"Intraoperative radiotherapy for advanced carcinoma of the biliary system","volume":"46","author":"Todoroki","year":"1980","journal-title":"Cancer"},{"key":"10.1080\/13651820701216216_bb0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0360-3016(95)02032-2","article-title":"A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma","volume":"34","author":"Hsue","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1080\/13651820701216216_bb0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1995.13.1.227","article-title":"Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial","volume":"13","author":"Whittington","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1080\/13651820701216216_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/IJGC:35:1:001","article-title":"Photodynamic therapy for pancreatic and biliary tract carcinoma","volume":"35","author":"Ayaru","year":"2005","journal-title":"Int J Gastrointest Cancer"},{"key":"10.1080\/13651820701216216_bb0180","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","article-title":"Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study","volume":"125","author":"Ortner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1080\/13651820701216216_bb0185","series-title":"The effective management of upper gastrointestinal malignancies","article-title":"Investigation and management of biliary tract cancer","author":"Armstrong","year":"2005"},{"key":"10.1080\/13651820701216216_bb0190","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.annonc.a010676","article-title":"Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer","volume":"7","author":"Glimelius","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1080\/13651820701216216_bb0195","first-page":"2020","article-title":"Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial","volume":"45","author":"Takada","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.1080\/13651820701216216_bb0200","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/annonc\/mdh096","article-title":"Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial","volume":"15","author":"Kornek","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1080\/13651820701216216_bb0205","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejca.2004.10.026","article-title":"EORTC Gastro Intestinal Tract Cancer Group. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial","volume":"41","author":"Ducreux","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1080\/13651820701216216_bb0210","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.bjc.6602576","article-title":"Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer","volume":"92","author":"Rao","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1080\/13651820701216216_bb0215","unstructured":"Valle JW, Wasan H, Johnson P, Bridgewater J, Maraveyas A, Jones E, et al. Gemcitabine, alone or in combination with cisplatin, in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised phase II study. ASCO GI January 2006."},{"key":"10.1080\/13651820701216216_bb0220","doi-asserted-by":"crossref","unstructured":"Pereira S, Ragunath K, Devlin J, Meadows H. Preliminary results of a phase 2 trial to examine the safety and efficacy of porfimer sodium PDT in locally advanced BTC. ASCO Proceedings 2005.","DOI":"10.1200\/jco.2005.23.16_suppl.4180"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15310194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15310194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:49:34Z","timestamp":1761263374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X15310194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1365182X15310194"],"URL":"https:\/\/doi.org\/10.1080\/13651820701216216","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New advances in the management of biliary tract cancer","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/13651820701216216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}